Electrical Stimulation to Accelerate Wound Healing

Last updated: April 13, 2022
Sponsor: Baylor College of Medicine
Overall Status: Completed

Phase

N/A

Condition

Peripheral Neuropathy

Diabetic Kidney Disease

Claudication

Treatment

N/A

Clinical Study ID

NCT03821675
H-44704
  • Ages 18-85
  • All Genders

Study Summary

A clinical study at the Baylor College of Medicine, Division of Vascular Surgery and Endovascular Therapy, is being proposed to test the efficacy of a novel electrical stimulation platform named the Tennant Biomodulator designed by AVAZZIA to accelerate wound healing, relieve pain and improve mobility in patients with diabetic foot ulcers.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Able to provide informed consent
  • 18-85 years old
  • Clinically confirmed diabetes (ADA criteria)
  • Clinically confirmed Peripheral Neuropathy
  • One or more active non-infected ulcers
  • Subject or responsible caregiver is willing and to maintain the required offloading (as applicable the location of the ulcer) and applicable dressing changes andelectrical stimulation application.

Exclusion

Exclusion Criteria:

  • Subject has a demand-type cardiac pacemaker, implanted defibrillator or otherimplanted electronic device
  • Is pregnant
  • Is nursing or actively lactating
  • Has Renal Disease
  • Active wound infection
  • Active Charcot foot
  • Non-ambulatory (unable to walk 40 feet with or without assistive device)
  • Bilateral AK/BK amputation
  • Active drug/alcohol abuse
  • Dementia or impaired cognitive function
  • Excessive lymphedema
  • Osteomyelitis and/or gangrene
  • Unable to comply with research appointments (e.g. long travel) Wide spread malignancyor systemically imumno-compromising disease
  • Subject has a history of or any intercurrent illnesses or conditions that wouldcompromise the safety of the subject according to judgement of a qualified woundspecialist.

Study Design

Total Participants: 38
Study Start date:
February 28, 2019
Estimated Completion Date:
October 08, 2021

Study Description

Electrical stimulation may offer a unique treatment option to heal complicated and recalcitrant wounds, improve flap and graft survival, and even reduce the likelihood of ulceration. Electrical stimulation has been suggested to reduce infection, improve cellular immunity, increase perfusion, relieve pain, improve plantar sensation, and accelerate wound healing.

Electrical stimulation could have positive effect on not only increasing skin perfusion in patients with diabetes but also could improve mobility and balance via enhancing plantar sensation as demonstrated in our recent study. Thus, plantar stimulation not only may be beneficial to accelerate wound healing in diabetic foot ulcer (DFU) patients but also may assist to improve mobility and reduce the likelihood of recurrence of ulcers.

This study is proposed to examine the effectiveness of an innovative portable electrical stimulation platform (Tennant Biomodulator by AVAZZIA) to accelerate wound healing in DFU patients. It is hypothesized that 1) electrical stimulation will have an immediate effect on increasing skin perfusion (immediate benefit) and 2) daily use of the Tennant Biomodulator for 4 consecutive weeks is effective to speed up wound healing, increase skin perfusion, reduce pain, and improve balance and mobility in DFU patients (long term benefit)

Connect with a study center

  • Baylor College of Medicine

    Houston, Texas 77030
    United States

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.